Phenotype: Glycogen storage disease II


OMIM: 232300
Inheritance: Autosomal recessive
Classification: Endocrine, nutritional and metabolic disease

Related informations: Orphanet    Gene Tests    Clinical Synopsis    Clinical Trials

GAA || exon 18 deletion

Gene/Locus:    GAA
Dna Change:    exon 18 deletion
Protein Change:   
Mutation Type:    Deletion
Mutation Effect:    Others
Location:    exon 18
Transcript:    NM_000152.3

PopulationEthnic GroupRegionMutation FrquencyCoalescence TimeReference
ItalyNASicily5 patients/25 patientsNADagnino F et al., 2000Dagnino F, Stroppiano M, Regis S, Bonuccelli G, Filocamo M, . Evidence for a founder effect in Sicilian patients with glycogen storage disease type II.. Hum. Hered.. 2000; 50(6):331-3
ItalyNASicily5 patients/25 patientsNADagnino F et al., 2000Dagnino F, Stroppiano M, Regis S, Bonuccelli G, Filocamo M, . Evidence for a founder effect in Sicilian patients with glycogen storage disease type II.. Hum. Hered.. 2000; 50(6):331-3

References

Dagnino F, Stroppiano M, Regis S, Bonuccelli G, Filocamo M, Evidence for a founder effect in Sicilian patients with glycogen storage disease type II.Hum. Hered.. 2000; 50(6):331-3